Olga Uspenskaya

Company: Prevail Therapeutics

Job title: VP clinical development

Seminars:

Modulating AAV-Mediated Immune Response Depending on Route of Administration & Underlying Disease 11:30 am

Consideration for prophylactic immunomodulation/immunosuppression depending on AAV-based gene therapy route of administration Finding a subtle balance between safe immunomodulation and sufficient suppression of AAV-driven immune response Additional safety considerations as they relate to immunosuppression when treating frail patient populationsRead more

day: Day 2 Tracks 2 AM